Today's Big Stories

ARVs soon to be available to all HIV patients, irrespective of CD4 count

Health Minister Aaron Motsoaledi has announced that all HIV-positive South Africans will have access to anti-retroviral drugs (ARVs) by September this year.

The CD4 eligibility criterion for ARV medication will be removed from healthcare policies after clinical evidence showed the benefits of early treatment.

Leading HIV scientist Professor Salim Abdool Karim says that early treatment will reduce the chances of contracting an infectious disease or developing an AIDS-related illness.

We now know that these patients will do better. They will have fewer episodes of TB, fewer events relating to HIV such as pneumonia or meningitis, and they will have a close to normal life span.

Professor Salim Abdool Karim, Director for the Centre for Aids Program of Research in South Africa

In addition, early treatment may provide preventative benefits as the ARVs decrease a patient's level of infectiousness.

Listen to the full conversation from The Midday Report:

702 welcomes all comments that are constructive, contribute to discussions in a meaningful manner and take stories forward.

However, we will NOT condone the following:

  • Racism (including offensive comments based on ethnicity and nationality)
  • Sexism
  • Homophobia
  • Religious intolerance
  • Cyber bullying
  • Hate speech
  • Derogatory language
  • Comments inciting violence.

We ask that your comments remain relevant to the articles they appear on and do not include general banter or conversation as this dilutes the effectiveness of the comments section.

We strive to make the 702 community a safe and welcoming space for all.

702 reserves the right to: 1) remove any comments that do not follow the above guidelines; and, 2) ban users who repeatedly infringe the rules.

Should you find any comments upsetting or offensive you can also flag them and we will assess it against our guidelines.

702 is constantly reviewing its comments policy in order to create an environment conducive to constructive conversations.

Read More
New calls for medical aid schemes to pay for HIV prevention drugs

New calls for medical aid schemes to pay for HIV prevention drugs

Medical aid companies stand to benefit from preventative HIV care packages for clients, says healthcare funder Dr Humphrey Zokufa.

Drugs will reduce risk of getting HIV - Health department on board

Drugs will reduce risk of getting HIV - Health department on board

The use of ARV's as a pre-exposure drug has proved highly effective in reducing the risk of people contracting HIV.

Male sexual health and the new HIV preventive drug explained

Male sexual health and the new HIV preventive drug explained

Dr Shingai Mutambirwa tackles listeners' questions on male sexual health and talks about Truvada, the new HIV preventive drug.

Medicines Control Council approves HIV prevention drug

Medicines Control Council approves HIV prevention drug

In a ground-breaking development, South Africans will have access to Truvada, a new drug that will reduce their chances of HIV infection.

Health Dept encourages combination prevention after HIV Truvada pill approved

Health Dept encourages combination prevention after HIV Truvada pill approved

A new HIV treatment and prevention pill, Truvada, has been approved by the Medicines Control Council.

'Life expectancy 10% higher since emergence of effective ARV treatment'

'Life expectancy 10% higher since emergence of effective ARV treatment'

Effective treatment and scientific research is said to have had a positive effect on the life expectancy of those diagnosed with HIV.

Stigma remains a problem in many communities, says HIV/Aids activist

Stigma remains a problem in many communities, says HIV/Aids activist

Andile Madondile was diagnosed with HIV in 2003 and has since been living openly and working with several advocacy groups in Cape Town.

'We need to refocus on prevention of HIV infections' - Prof Helen Rees

'We need to refocus on prevention of HIV infections' - Prof Helen Rees

The Wits Reproductive Health and HIV Institute's Professor Helen Rees says we need to refocus on prevention of HIV infections.

Fewer deaths in SA than any time since 2001 (and 4 other insights from Stats SA)

Fewer deaths in SA than any time since 2001 (and 4 other insights from Stats SA)

Flu kills more South Africans of all ages than HIV. This and other surprising insights from Stats SA’s latest mortality report.

Popular articles
It's not the end of the road... Top tips to improve your matric

It's not the end of the road... Top tips to improve your matric

"Recognise that it’s not the end, it’s the beginning." Expert advise for school-leavers who want to improve their results.

NSFAS to reopen 2017 applications

NSFAS to reopen 2017 applications

National Student Financial Aid Scheme says it will reopen 2017 loan applications after receiving requests for deadline extension.

How to build an African art portfolio (that'll grow in value)

How to build an African art portfolio (that'll grow in value)

Walker Scott Art Advisory’s Dr Fred Scott gives advice on building a high growth African art portfolio.

Right now, these are the best shares to buy on the JSE (according to Adviceworx)

Right now, these are the best shares to buy on the JSE (according to Adviceworx)

Bruce Whitfield interviews a Portfolio Manager about what she believes are the hottest stocks right now.

3 easy questions could bag you R2000!

3 easy questions could bag you R2000!

WIN R2000! But only if you can prove you're a whiz of the MTN Biz Quiz by answering the following three questions...

Blesserfinder: Matching you with a sugar daddy near you

Blesserfinder: Matching you with a sugar daddy near you

Is social trend Blesserfinder, where girls are allegedly matching up with rich 'benefactors' in exchange for sex, a real thing?

5 reasons why the tourism industry is sceptical about the latest numbers

5 reasons why the tourism industry is sceptical about the latest numbers

The tourism industry is questioning the veracity of the surprisingly upbeat tourism figures and the timing of their release.